Apps

London GPs can now refer leading mental health apps for free

IQVIA has partnered with Healthy London Partnership to enable 75% of GPs across London who have access to EMIS App Library by AppScript® to recommend 4 clinically-validated, reimbursed digital therapeutic apps to their patients.

The apps recommended include:

  • Sleepio (by Big Health)
  • Be Mindful (by WellMind Media)
  • My Possible Self
  • MyCognition

The move sees Good Thinking, London’s digital well-being service, in collaboration with IQVIA and EMIS Health, enable London GPs to digitally refer health apps to their patients.

Good Thinking provides more than 120 safe, proactive and early intervention tools to Londoners who are experiencing mental health and wellbeing concerns. Some 245,000 people in the capital currently use the service and about 15,000 people use Good Thinking each month.

Dr Vin Diwakar, Regional Medical Director for London NHS England and NHS Improvement “Mental health problems are common and more people are looking for new ways to help to improve their wellbeing than ever before. One in four adults will experience mental illness at some point in their lives. Most people who experience mental health problems recover fully, or are able to live with and manage them, especially if they get help early on. Digital technology presents us with new opportunities to deliver NHS services differently, enabling more people to access the treatment and support they need.”

“This is a great example of what we need to see in a modern NHS world that places the patient needs at the heart of everything we do, ensuring we design the service around what people need and when they need it the most.”

Brian Clancy, Co-Lead and Associate Director of AppScript® by IQVIA “This is a significant milestone for digital therapeutics in general, which has until this point struggled to align prescribing workflows with complex reimbursement pathways at meaningful scale. We look forward to bringing together similar digital therapeutics prescribing and reimbursement ecosystems in additional regions around the world with an initial focus on the UK.”